NCT05221684

Brief Summary

This study aims to evaluate the value of the LNR as a prognostic indicator in patients with rectal cancer who offered total mesorectal excision.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 9, 2020

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

January 23, 2022

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 3, 2022

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

February 3, 2022

Status Verified

January 1, 2022

Enrollment Period

1.6 years

First QC Date

January 23, 2022

Last Update Submit

January 23, 2022

Conditions

Recurrence

Outcome Measures

Primary Outcomes (1)

  • Lymph node value

    Value in prediction of oncological outcomes

    one year

Interventions

Lymph node harvestingPROCEDURE

Lymph node harvesting after radical resection for rectal cancer with curative intent

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with rectal cancer TNM stage I-III Who underwent surgery with curative intent

You may qualify if:

  • rectal cancer of TNM stage I-III
  • underwent radical resection with curative intent

You may not qualify if:

  • synchronous colon cancer
  • synchronous gastrointestinal cancer
  • underwent palliative resection
  • presented with intestinal obstruction
  • those lost to follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura Faculty of Medicine

Al Mansurah, Dakahliya, 35516, Egypt

Location

MeSH Terms

Conditions

Recurrence

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Mostafa Shalaby

    Mansoura Faculty of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Colorectal Surgery

Study Record Dates

First Submitted

January 23, 2022

First Posted

February 3, 2022

Study Start

June 9, 2020

Primary Completion

January 31, 2022

Study Completion

December 31, 2022

Last Updated

February 3, 2022

Record last verified: 2022-01

Locations

EG(1)